Use of over-the-scope clip (OTSC) versus standard therapy for the prevention of rebleeding in large peptic ulcers (size ≥1.5 cm): an open-labelled, multicentre international randomised controlled trial

Shannon M. Chan, Rapat Pittayanon, Hsiu-Po Wang, Jiann‐Hwa Chen, Anthony Yuen Bun Teoh, Yu‐Ting Kuo, Raymond S. Tang, Hon Chi Yip, Stephen Ka Kei Ng, Sunny H. Wong, Joyce Wing Yan Mak, Heyson Chi-hey Chan, Louis Ho Shing Lau, Rashid N. Lui, Marc Wong, Rungsun Rerknimitr, Enders K. Ng, Philip Wai Yan ChiuGut 2022 · DOI

Abstract: NCT03160911. This multicentre randomized controlled trial (RCT) investigated whether using Over-the-Scope Clips (OTSC) as a first-line treatment for large (≥1.5 cm) bleeding peptic ulcers reduces rebleeding compared to standard therapy. While OTSC significantly reduced rebleeding in cases where it was successfully applied, the study found no statistically significant difference in the overall patient group (intention-to-treat), highlighting technical challenges in specific anatomical locations.

Introduction

Peptic ulcer bleeding is a common medical emergency. While most cases are managed effectively with standard endoscopic techniques—such as small through-the-scope clips, thermal probes, or epinephrine injections—"giant" ulcers (defined as ≥1.5 cm) remain a high-risk subgroup. These large ulcers are associated with rebleeding rates as high as 23%, which is a major predictor of patient mortality.

The Over-the-Scope Clip (OTSC), often nicknamed the "bear claw" due to its robust design and strength, has established efficacy as a "salvage" therapy for ulcers that recur after initial treatment. This study investigated whether OTSC could be used effectively as a primary (first-line) tool to prevent that initial rebleeding in high-risk large ulcers.

Methods

This open-labelled, multicentre international RCT was conducted across six hospitals in Hong Kong, Thailand, Taiwan, and China between July 2017 and October 2020.

Participants and Intervention

A total of 100 patients with large peptic ulcers (≥1.5 cm) exhibiting high-risk features (active spurting, oozing, or a non-bleeding visible vessel) were recruited. Participants were randomized into two groups:

  • OTSC Group (n=50): Received primary treatment using the OTSC device.
  • Standard Group (n=50): Received combination therapy using at least two standard methods (e.g., epinephrine injection plus either a heater probe or standard clips).

Analysis

The primary outcome was clinical rebleeding within 30 days. The study used an "intention-to-treat" (ITT) analysis, meaning everyone randomized was included in the final count, regardless of whether the procedure was technically successful.

Key Results

The study revealed a notable difference between the overall group results and the outcomes for patients where the procedure was technically successful.

Comparison of rebleeding rates between OTSC and standard therapy groups.

In the ITT analysis, the 30-day rebleeding rate was 10% in the OTSC group compared to 18% in the standard group. While lower, this difference did not reach statistical significance (p=0.23). However, when analyzing only those cases where the OTSC was successfully applied, the rebleeding rate dropped to 4.35%, compared to 18.75% in the standard therapy group (p=0.03).

Cumulative hazard of rebleeding over 30 days for technically successful procedures.

Primary haemostasis was achieved in 92% of the OTSC group and 96% of the standard group. Secondary endpoints, including 30-day mortality (4% OTSC vs. 8% standard), blood transfusion requirements, and length of hospital stay, showed no significant differences between the two arms.

Discussion and Technical Challenges

The "success gap" between ITT and per-protocol results highlights significant technical barriers. The technical failure rate for OTSC was 8%, with all four failures occurring at the junction of the first and second parts of the duodenum (D1/2). This anatomical location is notoriously difficult due to unstable scope positioning and awkward angles for bulky devices like the OTSC.

Furthermore, the study highlighted a "misfire penalty": a misplaced OTSC is bulky and made of nitinol, which can obstruct the endoscopic view or prevent the application of subsequent salvage tools. Despite the participating endoscopists being experts (having performed >20 OTSC procedures), the failure rate suggests that treating giant ulcers requires a higher level of technical proficiency than smaller lesions.

Limitations and Conclusion

The study may have been underpowered to detect a significant difference in the ITT population, as the actual rebleeding rate in the OTSC arm (10%) was higher than the 5% expected by the researchers. The high failure rate in specific duodenal locations suggests that OTSC may not be the optimal first-line choice for all large ulcers, particularly those in difficult anatomical positions, unless performed by ultra-specialized experts. Future research should focus on identifying optimal experience thresholds and better pre-application assessment tools.

Summary updated

Abstract

NCT03160911.
BibTeX
@inproceedings{chan2022use,
  author = {Shannon M. Chan and Rapat Pittayanon and Hsiu-Po Wang and Jiann‐Hwa Chen and Anthony Yuen Bun Teoh and Yu‐Ting Kuo and Raymond S. Tang and Hon Chi Yip and Stephen Ka Kei Ng and Sunny H. Wong and Joyce Wing Yan Mak and Heyson Chi-hey Chan and Louis Ho Shing Lau and Rashid N. Lui and Marc Wong and Rungsun Rerknimitr and Enders K. Ng and Philip Wai Yan Chiu},
  title = {{Use of over-the-scope clip (OTSC) versus standard therapy for the prevention of rebleeding in large peptic ulcers (size ≥1.5 cm): an open-labelled, multicentre international randomised controlled trial}},
  booktitle = {Gut},
  year = {2022},
  doi = {10.1136/gutjnl-2022-327007},
}
Figure